Ryan Gupta
University of California, Irvine
13 Papers
4 Citations
Ryan Gupta is an academic researcher from University of California, Irvine. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 3, co-authored 4 publications.
Chat about Author
Papers
Factors Associated With Successful Median Arcuate Ligament Release in an International, Multi-Institutional Cohort.
Charles DeCarlo,Karen Woo,André S. van Petersen,Robert H. Geelkerken,Alina J. Chen,Savannah L. Yeh,Gloria Y Kim,Peter K. Henke,Margaret C. Tracci,M. Schneck,D. Grotemeyer,Bernd U. Meyer,Randall R. De Martino,Parvathi B. Wilkins,Sina Iranmanesh,Vinamr Rastogi,Bernadette Aulivola,Lindsey M. Korepta,William P. Shutze,K. Jett,Rebecca Sorber,Christopher J. Abularrage,Graham W. Long,Paul Bove,Mark G. Davies,Dimitrios Miserlis,Michael Shih,Jeniann A. Yi,Ryan Gupta,Jacky Loa,David A. Robinson,Alexander Gombert,Panagiotis Doukas,Giovanni De Caridi,F. Benedetto,Catherine M. Wittgen,Matthew R. Smeds,Bauer E. Sumpio,Sean E. Harris,Zoltán Szeberin,Enikő Pomozi,Francesco Stilo,Nunzio Montelione,Nicolas J. Mouawad,Peter F. Lawrence,Anahita Dua +45 more
TL;DR: In this paper , the authors compared the outcomes of different approaches to MALR and determined the predictors of long-term treatment failure, defined as no improvement in median arcuate ligament syndrome symptoms after MR, or symptom recurrence between MR and the last clinical follow-up.
19
A comprehensive review on antithrombotic therapy for peripheral artery disease.
TL;DR: The existing literature and guidelines regarding the use of antithrombotic therapy in patients with PAD are analyzed and a framework is offered to aid clinicians' decision making regarding therapy selection and duration based on current existing evidence.
11
Novel Tissue Factor Inhibition for Thromboprophylaxis in COVID-19: Primary Results of the ASPEN-COVID-19 Trial.
Connie N. Hess,Judith Hsia,Ian A. Carroll,Mark R. Nehler,Wolfram Ruf,David A. Morrow,Jose C. Nicolau,Otavio Berwanger,Michael Szarek,Warren H. Capell,Shilpa Johri,Ryan Gupta,Francesco Franchi,Mark B. Effron,Debra Marshall,Christopher A. Graybill,Thomas Alan Keuer,Michael Bristow,Marc P. Bonaca +18 more
TL;DR: In this article , the safety and efficacy of the novel TF inhibitor rNAPc2 (recombinant nematode anticoagulation protein c2) in COVID-19 are unknown.
3
High Rates of Recurrent Revascularization in Acute Limb Ischemia - a National Surgical Quality Improvement Program Study.
TL;DR: In this paper , the authors queried the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database to review outcomes of acute limb ischemia patients following open surgical intervention for ALI.
3
The Effect of Medical School Reputation and Alpha Omega Alpha Membership on the Orthopedic Residency Match in the United States
TL;DR: Top 25 orthopedic residency programs matched more applicants who had attended top 25 medical schools and who were AOA members than all other Orthopedic programs.
3